| Celgene Signs US$500 M Next-Generation Antibody Deal with Sutro Biopharma |
Abstract
|
|
Heather Cartwright |
|
| Halozyme’s Enhanze™ Technology Gains Much-Needed Boost with Pfizer Collaboration |
Abstract
|
|
Heather Cartwright |
|
| MacroGenics Gains Another DART™ Collaborator in Gilead |
Abstract
|
|
Heather Cartwright |
|
| Amgen Invests in Nanomedicine with BIND Biosciences Collaboration |
Abstract
|
|
Heather Cartwright |
|
| AstraZeneca and Vanderbilt University Partner to Develop Drugs for Major Brain Disorders |
Abstract
|
|
Heather Cartwright |
|
| Dutch Start-Up Dezima Pharma In-Licenses First Pipeline Drug from Mitsubishi Tanabe |
Abstract
|
|
Heather Cartwright |
|
| Pernix Therapeutics Agrees to Buy Beleaguered Somaxon Pharmaceuticals |
Abstract
|
|
Heather Cartwright |
|
| The Medicines Company Strengthens its Perioperative Care Franchise via Deals with Incline Therapeutics and BMS |
Abstract
|
|
Heather Cartwright |
|
| Gilead to Strengthen Oncology Pipeline with YM BioSciences Purchase |
Abstract
|
|
Heather Cartwright |
|
| Allergan Looks to Boost Migraine Business with MAP Pharmaceuticals Purchase |
Abstract
|
|
Heather Cartwright |
|
| Teva Forms Joint Venture with Handok Pharmaceuticals to Tap South Korean Market |
Abstract
|
|
Heather Cartwright |
|
